Seek Labs secures a $2 million federal grant to develop a CRISPR-based therapeutic targeting avian flu in collaboration with the Canadian Food Inspection Agency. This funding is part of a broader initiative to combat the highly infectious avian influenza impacting poultry production.
USDA grant is part of a broader federal push to find innovative solutions to fight the highly infectious avian flu (HPAI), which continues to spread globally and impact egg and poultry production · SALT LAKE CITY--(BUSINESS WIRE)--#AvianInfluenza--Seek Labs, a private TechBio company building ... Seek Labs is a TechBio company approaching disease differently. We rebuilt the fundamental building blocks of disease response into a programmable system to detect, protect, and counter disease threats. SALT LAKE CITY--(BUSINESS WIRE)--#AvianInfluenza--Seek Labs, a private TechBio company building a programmable disease response platform to detect, protect, and counter disease threats, has been awarded $2 million from the U.S. As part of the award, Seek Labs will also collaborate with the Canadian Food Inspection Agency (CFIA). The award’s Principal Investigators are Douglas Gladue, Vice President of Veterinary Pharma at Seek Labs and Yohannes Berhane, Head of the Avian Disease Research Unit at CFIA. At the core of this system is an AI-powered intelligence layer that transforms raw biology into actionable data, informing two deployment layers across programmable therapeutics and molecular point-of-care diagnostics. The validated deployment layer insights feed back into the core to create a continuous, data-driven improvement loop, transforming how the world can detect and treat disease.
Original title: “Seek Labs Awarded $2 Million Federal Grant for a Novel CRISPR-Based, Mutation-Resistant Therapeutic to Combat Avian Flu in Partnership with Canadian Food Inspection Agency - BioSpace”